Vyome Holdings lists as Hind on Nasdaq
BENGALURU: Vyome Holdings, created through the merger of biotech startup Vyome Therapeutics and Nasdaq-listed ReShape Lifesciences, began trading on Friday under the ticker ‘Hind’, with Vyome shareholders holding a controlling 91.6% stake in the combined company. The debut coincided with India’s 79th Independence Day.
